Report Description

India acyclovir market is expected to grow at a steady rate during the forecast period. Acyclovir is an anti-viral drug used for the treatment of diseases such as chickenpox, hepatitis, among others. Acyclovir helps in reducing severity, pain and healing of sores or blisters in chicken pox. The growing prevalence of these viral infections is expected to drive the growth of India acyclovir market during the forecast period. Additionally, acyclovir is used in the prevention of outbreak of genital herpes. This in turn is expected to fuel the market growth through FY2026.

The India acyclovir market is segmented based on source, form, route of administration, type of virus, mechanism of action, distribution channel, application, end user, company and region. Based on source, the market can be split into in-house and contract manufacturing organizations. The in-house segment is expected to dominate the market since most of the players operating in the market have their own setups where they are manufacturing the drug. Based on distribution channel, the market can be split into online and offline. The online segment is expected to witness significant growth through FY2026 on account of the emergence of several online pharmacies, digital and e-commerce platforms.

The major players operating in the India acyclovir market are Cipla Limited, Agio Pharmaceuticals Limited, Zee Laboratories Limited, Novus Life Sciences Pvt. Ltd., Terrace Pharmaceuticals Pvt. Ltd., Grefith Life Sciences Private Limited, Samarth Life Sciences Pvt. Ltd., Novartis India Limited (Sandoz Private Limited), Cadila Healthcare Limited, Eli Lilly and Company India Pvt Ltd. and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies and launching new products in order to stay competitive in the market.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India acyclovir market from FY2016 to FY2019.
  • To estimate and forecast the market size of India acyclovir market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India acyclovir market based on source, form, route of administration, type of virus, mechanism of action, distribution channel, application, end user, company and regional distribution.
  • To identify dominant region or segment in the India acyclovir market.
  • To identify drivers and challenges for India acyclovir market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India acyclovir market.
  • To identify and analyze the profile of leading players operating in India acyclovir market.
  • To identify key sustainable strategies adopted by market players in India acyclovir market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India acyclovir market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Acyclovir manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to acyclovir

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India acyclovir market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Acyclovir Market, By Source:
    • In-House
    • Contract Manufacturing Organizations
  • India Acyclovir Market, By Form:
    • Tablet
    • Capsule
    • Ointment/Cream
    • Injection
    • Powder for Solution
    • Others
  • India Acyclovir Market, By Route of Administration:
    • Oral
    • Injectable
    • Topical
    • Others
  • India Acyclovir Market, By Type of Virus:
    • Herpes Simplex Virus Type I (HSV-1)
    • Herpes Simplex Virus Type II (HSV-2)
    • Varicella Zoster Virus (VZV)
    • Epstein-Barr Virus (EBV)
    • Cytomegalovirus (CMV)
  • India Acyclovir Market, By Mechanism of Action:
    • Nucleotide Polymerase Inhibitors
    • Reverse Transcriptase Inhibitors
    • Protease Inhibitors
    • Others
  • India Acyclovir Market, By Distribution Channel:
    • Online
    • Offline
  • India Acyclovir Market, By Application:
    • Cold Soares
    • Chickenpox
    • Genital Herpes
    • Shingles
    • Hepatitis
    • HIV
    • Influenza
    • Others
  • India Acyclovir Market, By End User:
    • Children up to 12 years
    • Adults
  • India Acyclovir Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India acyclovir market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India Acyclovir market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Acyclovir Market

4.    Executive Summary

5.    Manufacturing Acyclovir

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Acyclovir

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Acyclovir Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.2.     By Form (Tablet, Capsule, Ointment/Cream, Injection, Powder for Solution, Others)

7.2.3.     By Route of Administration (Oral, Injectable, Topical, Others)

7.2.4.     By Type of Virus (Herpes Simplex Virus Type I (HSV-1), Herpes Simplex Virus Type II (HSV-2), Varicella Zoster Virus (VZV), Epstein-Barr Virus (EBV), Cytomegalovirus (CMV))

7.2.5.     By Mechanism of Action (Nucleotide Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Others)

7.2.6.     By Distribution Channel (Online v/s Offline)

7.2.7.     By Application (Cold Soares, Chickenpox, Genital Herpes, Shingles, Hepatitis, HIV, Influenza, Others)

7.2.8.     By End User (Children up to 12 years v/s Adults)

7.2.9.     By Region (North, East, South, West)

7.2.10.  By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Cipla Limited

14.1.1.1.      Company Brief

14.1.1.2.      Production Plants & Capacity (If Available)

14.1.1.3.      Financials (If Available)

14.1.1.4.      Captive Consumption Vs Merchant Sale

14.1.1.5.      Current & Future Plans

14.1.2.  Agio Pharmaceuticals Limited

14.1.3.  Zee Laboratories Limited

14.1.4.  Novus Life Sciences Pvt. Ltd.

14.1.5.  Terrace Pharmaceuticals Pvt. Ltd.

14.1.6.  Grefith Life Sciences Private Limited

14.1.7.  Samarth Life Sciences Pvt. Ltd.

14.1.8.  Novartis India Limited (Sandoz Private Limited)

14.1.9.  Cadila Healthcare Limited

14.1.10.                Eli Lilly and Company India Pvt Ltd

15.  Strategic Recommendations

16.  About Us & Disclaimer 

Figures and Tables

Frequently asked questions

down-arrow

down-arrow

down-arrow

down-arrow